Where we are: The FTSE 100 is posting modest gains of 0.3% to trade around 8,240, recovering from an overnight low of 8,195 as European cash trading progresses. The index is clawing back some of its weekly losses, which still stand at roughly 0.6% after yesterday’s post-BoE slide. Immediate resistance sits at 8,280, with a clean break there needed to reverse this week’s bearish bias, while the 50-day moving average at 8,185 provides critical support.
What’s driving it: UK retail sales rebounded by 1.2% m/m in May, easily beating the 0.5% consensus forecast and injecting fundamental resilience into domestic consumer-facing sectors. This demand strength comes alongside a sticky domestic inflation profile, where Core CPI recently ticked up to 2.6% YoY, justifying the Bank of England’s decision yesterday to maintain the Bank Rate at 3.75%. UK bank stocks are underperforming today as the market digests the PRA’s freshly released Basel 3.1 internal model adjustments, which are offsetting gains in defensive pharma giants like AstraZeneca. Gilt yields are tracking the firm domestic activity data higher, a move amplified by US 10-year Treasury yields pushing to 4.49% and tightening broader financial conditions.
- The 1.2% rebound in May UK Retail Sales signals robust household spending power, limiting the scope for aggressive near-term Bank of England rate cuts despite overall public sector borrowing hitting £23.3 billion.
- The Prudential Regulation Authority’s 06:00 BST consultation on Basel 3.1 market risk rules has introduced regulatory shifts for UK lenders, pulling Lloyds down 1.8% and acting as a major drag on the index’s financial sleeve.
- A stark sectoral divergence is keeping the index afloat, with defensive heavyweights AstraZeneca (+1.6%) and GSK (+0.9%) attracting inflows, while miners like Rio Tinto and Glencore slip up to 1.1% on global growth concerns.
NY session focus: Macro traders are focused on the US data dump at 08:30 ET, where an upside surprise in activity will fuel US yields and pressure global equity valuations. The tactical play is to buy defensive healthcare and aerospace names on dips, while remaining underweight the rate-sensitive banking sector. Watch the 8,200 level on the FTSE 100; a daily close below this floor opens the doors to the 8,150 zone. The pain trade is a sharp short-squeeze back above 8,280 if US data prints soft enough to spark a broad-based relief rally across European cash equities.